JPRN-UMIN000007500招募中未知
Hypothetical clinical trial of safety improvement by Triamsinolone in vitreous surgery - Safty of Triamsinolone in vitreous surgery
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine0 个研究点目标入组 500 人开始时间: 2013年9月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)The contraindications item in a triamcinolone acetonide package leaflet (1)This agent ingredient hypersensitivity 2)The contraindications item at the time of whole body medication of a steroid hormone agent (1)The patient of the infection in which effective antibacterial medicine does not exist, and the mycosis of the whole body, (2) The patient of digestive ulcer, (3) The patient of a mental disease, (4) The patient of a tubercular disease, (5) The patient of simple herpetic keratitis, (6)The patient of after cataract, (7)The patient of glaucoma, (8)The patient of hypertension, (9)The patient with electrolyte abnormalities, (10)The patient of thromboses, (11)The patient with the operative wound of the recent internal organs, and (12) acute myocardial infarction, (13)The patient judged that medication of a steroid hormone agent is not desirable for the caused eye disease of a patient and others, or systemic illness 3)The patient who this research responsibility (assignment) doctor accepted was unsuitable as a subject 4)The participation in other clinical study is unquestioned.
研究者
相似试验
招募中
1 期
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex)Kidney transplantationMedDRA version: 20.0Level: LLTClassification code: 10023438Term: Kidney transplant Class: 10042613CTIS2024-513459-34-00Medical University Of Vienna24
招募中
2 期
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex)2024-513459-34-00Medical University Of Vienna24
进行中（未招募）
不适用
Investigaton of Safety, Tolerability of two preparations in patients suffering from osteoarthritis of the hip or kneeEUCTR2009-010719-33-ATGebro Pharma GmbH500
招募中
3 期
A phase III/IV clinical study to assess the safety and efficacy of dendritic cell immunotherapy in advanced stage ovarian cancer.CTRI/2010/091/000596Instutute of Cellular Therapies Pvt. Ltd.50
已完成
4 期
A trial for evaluation of effectiveness and safety for dose reduction DTP-IPV vaccination in adulthealthy adultJPRN-UMIN000022793Tokyo Metropolitan Children's Medical Center80